Home | News & Events | IDEA News | Diabetes medication reduces dementia risk

Diabetes medication reduces dementia risk

Treating people with type 2 diabetes, also known as 'age-related diabetes' with antidiabetics reduces their risk for Alzheimer's and other types of dementia. The risk is most significantly reduced by the drug pioglitazone. Researchers of the German Center for Neurodegenerative Diseases draw this conclusion from an analysis of health insurance data. Their findings are published in the journal Annals of Neurology.

Read more on the Medicalxpress website.